Lv41
510 积分 2023-02-27 加入
Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease
1个月前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
1个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
1个月前
已完结
Chimeric antigen receptor cell therapy: A revolutionary approach transforming cancer treatment to autoimmune disease therapy
1个月前
已完结
CAR T-Cell Therapy for Rheumatic Diseases: What Does the Future Hold?
1个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
1个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1个月前
已完结
CAR T-cell therapy in SLE: A systematic review
1个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
1个月前
已完结
皖公网安备34019202002308
